Michigan’s Outbreak Worries Scientists. Will Conservative Outposts Keep Pandemic Rolling?

When Kathryn Watkins goes shopping these days, she doesn’t bring her three young children. There are just too many people not wearing masks in her southern Michigan town of Hillsdale. At some stores, “not even the employees are wearing them anymore,” said Watkins, who estimates about 30% of shoppers wear masks, down from around 70%… Read More »

India reports more than 330,000 new Covid cases, setting a fresh global record

India needs a brief but extensive lockdown to break the chain of coronavirus transmission and allow the medical community to recuperate, according to the national president of the Indian Medical Association. The South Asian nation is going through a disastrous second wave of Covid infections. Cases began rising in February and in subsequent months, large… Read More »

KHN’s ‘What the Health?’: Picking Up the Pace of Undoing Trump Policies

Can’t see the audio player? Click here to listen on SoundCloud. The Biden administration is speeding up the pace of efforts to undo Trump administration health policies. The two most recent: overturning a ban on fetal tissue research funded by the National Institutes of Health and canceling a last-minute extension of a Medicaid waiver for Texas.… Read More »

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status

PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall survival versus chemotherapy alone in a trial of this patient population1 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma, Regardless… Read More »